ACE Pharmaceuticals has sold a majority stake to private investors and Quadrum Capital
The shareholders of ACE Pharmaceuticals have sold a majority stake in the company to private investors and Quadrum Capital, a Dutch private equity firm.
ACE Pharmaceuticals is a specialized company operating in the niche of medical need products which provide mainly small patient groups or specific indications. Through new, innovative products or by the revitalization of orphaned drugs, the company is able to ensure that these medical need products are or remain available. The company develops and distributes locally and abroad both licensed and non-licensed products. ACE Pharmaceuticals was founded more than 25 years ago as a producer of veterinary medicines. In the early 2000s, the company shifted its focus to human medical need products. Since then, it has experienced strong sales growth and has built an exciting product range and promising product pipeline.
Oaklins's team in the Netherlands acted as M&A advisor to the shareholders of ACE Pharmaceuticals in this transaction.
Neem contact op met het dealteam
Sander van 't Spijker
Oaklins Netherlands
Gerelateerde deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Lees verderCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Lees verderiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Lees verder